logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ketoconazole/MetyraponeHepatotoxicity and off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2032卷 / 1期
关键词:
D O I:
10.1007/s40278-024-69889-x
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:228 / 228
相关论文
共 50 条
  • [31] SintilimabFasciitis following off-label use: case report
    Reactions Weekly, 2021, 1884 (1) : 391 - 391
  • [32] HydroxychloroquineEosinophilia following off-label use: case report
    Reactions Weekly, 2021, 1867 (1) : 204 - 204
  • [33] GlibenclamideHypoglycaemia following an off-label use : case report
    Reactions Weekly, 2021, 1866 (1) : 190 - 190
  • [34] HydroxychloroquineHaemolysis following off-label use: case report
    Reactions Weekly, 2021, 1836 (1) : 376 - 376
  • [35] CannabidiolLiver disorder and off-label use: case report
    Reactions Weekly, 2021, 1882 (1) : 116 - 116
  • [36] Infliximab/nivolumabPsoriasis and off-label use: case report
    Reactions Weekly, 2023, 1984 (1) : 272 - 272
  • [37] Lapatinib/nivolumabFatigue and off-label use: case report
    Reactions Weekly, 2018, 1722 (1) : 200 - 200
  • [38] SpironolactoneHyperkalaemia secondary to off-label use: case report
    Reactions Weekly, 2021, 1836 (1) : 710 - 710
  • [39] ItraconazoleLack of efficacy and off-label use: case report
    Reactions Weekly, 2022, 1911 (1) : 254 - 254
  • [40] DenosumabLack of efficacy and off-label use: case report
    Reactions Weekly, 2022, 1909 (1) : 216 - 216
← 12345 →